Khurram Jamil insider trades: Galectin Therapeutics (GALT) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Khurram reports to the SEC
Open-market buys and sales
10 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 14, 2026 | GALT | ↓ Sell | 16,250 | $5.13 | $83K | Direct | Jul 16, 2026 (2d) |
| Jun 29, 2026 | GALT | ↓ Sell | 52,037 | $5.04 | $262K | Direct | Jun 30, 2026 (1d) |
| May 26, 2026 | GALT | ↓ Sell | 568 | $3.10 | $2K | Direct | May 28, 2026 (2d) |
| Jan 6, 2026 | GALT | ↓ Sell10b5-1 | 34,501 | $3.85 | $133K | Direct | Jan 6, 2026 (0d) |
| Jan 5, 2026 | GALT | ↓ Sell10b5-1 | 25,499 | $3.90 | $99K | Direct | Jan 6, 2026 (1d) |
| Dec 31, 2025 | GALT | ↓ Sell | 8,125 | $4.07 | $33K | Direct | Jan 5, 2026 (5d) |
| Dec 17, 2025 | GALT | ↓ Sell | 19,442 | $7.04 | $137K | Direct | Dec 19, 2025 (2d) |
| Nov 13, 2025 | GALT | ↓ Sell | 63,367 | $5.47 | $347K | Direct | Nov 14, 2025 (1d) |
| Nov 13, 2025 | GALT | ↓ Sell | 16,250 | $5.47 | $89K | Direct | Nov 14, 2025 (1d) |
| Dec 23, 2024 | GALT | ↓ Sell10b5-1 | 13,654 | $0.88 | $12K | Direct | Dec 26, 2024 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GALT insiders
Open-market trades in the last 12 months
About Khurram Jamil's insider trades
Khurram Jamil is Chief Medical Officer at Galectin Therapeutics (GALT). Since Dec 23, 2024, Khurram has reported no open-market purchases and 10 sales worth $1.2M on SEC Form 4. In the last 12 months: 9 sales ($1.2M).
3 sales (20% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (8 filings), grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GALT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.